<DOC>
	<DOC>NCT02124161</DOC>
	<brief_summary>The purpose of this study is to evaluate the immunogenicity and safety of 13-valent pneumococcal polysaccharide vaccine when given concomitantly with seasonal inactivated influenza vaccine to adults 50 years and older who have previously received 23-valent pneumococcal polysaccharide vaccine.</brief_summary>
	<brief_title>Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>1. Evidence of a personally signed and dated informed consent document (ICD) indicating that the subject has been informed of all pertinent aspects of the study. 2. Male or female adults 50 years of age or older. 3. Documented vaccination with 1 or more prior doses of 23vPS, the last given at least 1 year prior to study enrollment. 4. Negative urine pregnancy test for all female subjects who are of child bearing potential. 1. Previous vaccination with Prevnar®, Prevnar 13®, or any other investigational pneumococcal conjugate vaccine. 2. History of severe adverse reactions associated with any vaccine or vaccinerelated component. 3. Allergic to egg proteins (egg or egg products) and chicken proteins. 4. History of GuillainBarré syndrome. 5. Vaccination with any influenza vaccine within 6 months (182 days) before investigational product administration. 6. Documented S pneumoniae infection within the past 5 years before investigational product administration.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Pneumococcal polysaccharide vaccine</keyword>
	<keyword>13-valent pneumococcal conjugate vaccine</keyword>
	<keyword>invasive pneumococcal disease</keyword>
	<keyword>flu vaccine</keyword>
</DOC>